EDITORIALS

JCO's Special Series: More Is Better

Daniel G. Haller

JCO Aug 15 2004: 3207–3208. [Full Text] [PDF]

Assessing Prognosis in Non–Small-Cell Lung Cancer: Avenues to a More Complete Picture?

Steven M. Dubinett, David Elashoff, and Matthew Meyerson

JCO Aug 15 2004: 3209–3211. First published on Jul 12 2004; 10.1200/JCO.2004.05.931. [Full Text] [PDF]

Immunomodulatory Analogs of Thalidomide: An Emerging New Therapy in Myeloma

Paul Richardson and Kenneth Anderson

JCO Aug 15 2004: 3212–3214. First published on Jul 12 2004; 10.1200/JCO.2004.05.984. [Full Text] [PDF]

Patient Selection, Realism, and Randomized Clinical Trials

Joel E. Tepper

JCO Aug 15 2004: 3215–3217. First published on Jul 12 2004; 10.1200/JCO.2004.05.985. [Full Text] [PDF]

ORIGINAL REPORTS
Lung Cancer
	Upregulation of the Tissue Inhibitor of Metalloproteinase-1 Protein Is Associated With Progression of Human Non–Small-Cell Lung Cancer
	Ibrahim S. Aljada, Nithya Ramnath, Kathleen Donohue, Shashi Harvey, John J. Brooks, Sam M. Wiseman, Thaer Khoury, Gregory Loewen, Harry K. Slocum, Timothy M. Anderson, Gerold Bepler, and Dongfeng Tan
	JCO Aug 15 2004: 3218–3229. First published on Jul 12 2004; 10.1200/JCO.2004.02.110. [Abstract] [Full Text] [PDF]
	Expression of Hepatoma-Derived Growth Factor Is a Strong Prognostic Predictor for Patients With Early-Stage Non–Small-Cell Lung Cancer
	Hening Ren, Ximing Tang, J. Jack Lee, Lei Feng, Allen D. Everett, Waun Ki Hong, Fadlo R. Khuri, and Li Mao
	JCO Aug 15 2004: 3230–3237. [Abstract] [Full Text] [PDF]
	Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer
	Román Pérez-Soler, Abraham Chachoua, Lisa A. Hammond, Eric K. Rowinsky, Mark Huberman, Daniel Karp, James Rigas, Gary M. Clark, Pedro Santabárbara, and Philip Bonomi
	JCO Aug 15 2004: 3238–3247. [Abstract] [Full Text] [PDF]
	Positron Emission Tomography in Limited-Stage Small-Cell Lung Cancer: A Prospective Study
	Jeffrey D. Bradley, Farrokh Dehdashti, Mark A. Mintun, Ramaswamy Govindan, Kim Trinkaus, and Barry A. Siegel
	JCO Aug 15 2004: 3248–3254. [Abstract] [Full Text] [PDF]
	Preoperative F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value Predicts Survival After Lung Cancer Resection
	Robert J. Downey, Timothy Akhurst, Mithat Gonen, Alain Vincent, Manjit S. Bains, Steven Larson, and Valerie Rusch
	JCO Aug 15 2004: 3255–3260. [Abstract] [Full Text] [PDF]
	Population Variations in the Initial Treatment of Non–Small-Cell Lung Cancer
	Arnold L. Potosky, Scott Saxman, Robert B. Wallace, and Charles F. Lynch
	JCO Aug 15 2004: 3261–3268. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma
	S.A. Schey, P. Fields, J.B. Bartlett, I.A. Clarke, G. Ashan, R.D. Knight, M. Streetly, and A.G. Dalgleish
	JCO Aug 15 2004: 3269–3276. First published on Jul 12 2004; 10.1200/JCO.2004.10.052. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Phase III Study of Adjuvant Chemotherapy and Radiation Therapy Compared With Chemotherapy Alone in the Surgical Adjuvant Treatment of Colon Cancer: Results of Intergroup Protocol 0130
	James A. Martenson, Jr, Christopher G. Willett, Daniel J. Sargent, James A. Mailliard, John H. Donohue, Leonard L. Gunderson, Charles R. Thomas, Jr, Barbara Fisher, Al Bowen Benson, III, Robert Myerson, and Richard M. Goldberg
	JCO Aug 15 2004: 3277–3283. First published on Jul 12 2004; 10.1200/JCO.2004.01.029. [Abstract] [Full Text] [PDF]
	Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study
	O. Glehen, F. Kwiatkowski, P.H. Sugarbaker, D. Elias, E.A. Levine, M. De Simone, R. Barone, Y. Yonemura, F. Cavaliere, F. Quenet, M. Gutman, A.A.K. Tentes, G. Lorimier, J.L. Bernard, J.M. Bereder, J. Porcheron, A. Gomez-Portilla, P. Shen, M. Deraco, and P. Rat
	JCO Aug 15 2004: 3284–3292. [Abstract] [Full Text] [PDF]

Breast Cancer
	Randomized Trial of a Shared Decision-Making Intervention Consisting of Trade-Offs and Individualized Treatment Information for BRCA1/2 Mutation Carriers
	M.S. van Roosmalen, P.F.M. Stalmeier, L.C.G. Verhoef, J.E.H.M. Hoekstra-Weebers, J.C. Oosterwijk, N. Hoogerbrugge, U. Moog, and W.A.J. van Daal
	JCO Aug 15 2004: 3293–3301. [Abstract] [Full Text] [PDF]
	Breast Cancer With Synchronous Metastases: Trends in Survival During a 14-Year Period
	Fabrice Andre, Khemaies Slimane, Thomas Bachelot, Arianne Dunant, Moise Namer, Alain Barrelier, Omar Kabbaj, Jean Philippe Spano, Hugo Marsiglia, Roman Rouzier, Suzette Delaloge, and Marc Spielmann
	JCO Aug 15 2004: 3302–3308. [Abstract] [Full Text] [PDF]
	Patient Beliefs and Tamoxifen Discontinuance in Older Women With Estrogen Receptor—Positive Breast Cancer
	Aliza K. Fink, Jerry Gurwitz, William Rakowski, Edward Guadagnoli, and Rebecca A. Silliman
	JCO Aug 15 2004: 3309–3315. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study
	Jean-Jacques Patard, Hyung L. Kim, John S. Lam, Frederick J. Dorey, Allan J. Pantuck, Amnon Zisman, Vincenzo Ficarra, Ken-Ryu Han, Luca Cindolo, Alexandre De La Taille, Jacques Tostain, Walter Artibani, Colin P. Dinney, Christopher G. Wood, David A. Swanson, Claude C. Abbou, Bernard Lobel, Peter F.A. Mulders, Dominique K. Chopin, Robert A. Figlin, and Arie S. Belldegrun
	JCO Aug 15 2004: 3316–3322. [Abstract] [Full Text] [PDF]
	Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer
	Paul Mathew, Peter F. Thall, Donnah Jones, Cherie Perez, Corazon Bucana, Patricia Troncoso, Sun-Jin Kim, Isaiah J. Fidler, and Christopher Logothetis
	JCO Aug 15 2004: 3323–3329. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Early Detection and Prognosis of Ovarian Cancer Using Serum YKL-40
	Jakob Dupont, Meena K. Tanwar, Howard T. Thaler, Martin Fleisher, Noah Kauff, Martee L. Hensley, Paul Sabbatini, Sibyl Anderson, Carol Aghajanian, Eric C. Holland, and David R. Spriggs
	JCO Aug 15 2004: 3330–3339. [Abstract] [Full Text] [PDF]
	Phase II Study of Cisplatin and Vinorelbine in Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
	Mitchell Morris, John A. Blessing, Bradley J. Monk, Ramon McGehee, and David H. Moore
	JCO Aug 15 2004: 3340–3344. [Abstract] [Full Text] [PDF]

Melanoma
	The Microanatomic Location of Metastatic Melanoma in Sentinel Lymph Nodes Predicts Nonsentinel Lymph Node Involvement
	D.J. Dewar, B. Newell, M.A. Green, A.P. Topping, B.W.E.M. Powell, and M.G. Cook
	JCO Aug 15 2004: 3345–3349. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor Decrease Febrile Neutropenia After Chemotherapy in Children With Cancer: A Meta-Analysis of Randomized Controlled Trials
	Lillian Sung, Paul C. Nathan, Beverly Lange, Joseph Beyene, and George R. Buchanan
	JCO Aug 15 2004: 3350–3356. [Abstract] [Full Text] [PDF]
	Results of a Phase II Upfront Window of Pharmacokinetically Guided Topotecan in High-Risk Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumor
	Clinton F. Stewart, Lisa C. Iacono, Murali Chintagumpala, Stewart J. Kellie, David Ashley, W.C. Zamboni, M.N. Kirstein, Maryam Fouladi, Louis G. Seele, Dana Wallace, Peter J. Houghton, and Amar Gajjar
	JCO Aug 15 2004: 3357–3365. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Phase I and Pharmacokinetic Study of the Novel Oral Cell-Cycle Inhibitor Ro 31-7453 in Patients With Advanced Solid Tumors
	Jakob Dupont, Bryan Bienvenu, Carol Aghajanian, Sandra Pezzulli, Paul Sabbatini, Phothisath Vongphrachanh, Christine Chang, Christina Perkell, Kenneth Ng, Sharon Passe, Lars Breimer, Jianguo Zhi, Mark DeMario, David Spriggs, and Steven L. Soignet
	JCO Aug 15 2004: 3366–3374. [Abstract] [Full Text] [PDF]

Sarcomas
	Phase I Trial of Preoperative Doxorubicin-Based Concurrent Chemoradiation and Surgical Resection for Localized Extremity and Body Wall Soft Tissue Sarcomas
	Peter W.T. Pisters, Shreyaskumar R. Patel, Victor G. Prieto, Peter F. Thall, Valerae O. Lewis, Barry W. Feig, Kelly K. Hunt, Alan W. Yasko, Patrick P. Lin, Marc G. Jacobson, Michael A. Burgess, Raphael E. Pollock, Gunar K. Zagars, Robert S. Benjamin, and Matthew T. Ballo
	JCO Aug 15 2004: 3375–3380. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Health-Related Quality of Life Parameters As Prognostic Factors in a Nonmetastatic Breast Cancer Population: An International Multicenter Study
	Fabio Efficace, Patrick Therasse, Martine J. Piccart, Corneel Coens, Kristel Van Steen, Marzena Welnicka-Jaskiewicz, Tanja Cufer, Jaroslaw Dyczka, Michail Lichinitser, Lois Shepherd, Hanneke de Haes, Mirjam A. Sprangers, and Andrew Bottomley
	JCO Aug 15 2004: 3381–3388. [Abstract] [Full Text] [PDF]
	Acetaminophen (Paracetamol) Improves Pain and Well-Being in People With Advanced Cancer Already Receiving a Strong Opioid Regimen: A Randomized, Double-Blind, Placebo-Controlled Cross-Over Trial
	Martin Stockler, Janette Vardy, Avinesh Pillai, and David Warr
	JCO Aug 15 2004: 3389–3394. [Abstract] [Full Text] [PDF]

REVIEW ARTICLE
	Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site Group
	Alvaro Figueredo, Manya L. Charette, Jean Maroun, Melissa C. Brouwers, and Lisa Zuraw
	JCO Aug 15 2004: 3395–3407. First published on Jun 15 2004; 10.1200/JCO.2004.03.087. [Abstract] [Full Text] [PDF]

ASCO SPECIAL ARTICLE
	American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
	Al B. Benson, III, Deborah Schrag, Mark R. Somerfield, Alfred M. Cohen, Alvaro T. Figueredo, Patrick J. Flynn, Monika K. Krzyzanowska, Jean Maroun, Pamela McAllister, Eric Van Cutsem, Melissa Brouwers, Manya Charette, and Daniel G. Haller
	JCO Aug 15 2004: 3408–3419. First published on Jun 15 2004; 10.1200/JCO.2004.05.063. [Abstract] [Full Text] [PDF]

BIOLOGY OF NEOPLASIA
	Role of the Dependence Receptor DCC in Colorectal Cancer Pathogenesis
	Patrick Mehlen and Eric R. Fearon
	JCO Aug 15 2004: 3420–3428. [Abstract] [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

Serum Selenium in Lymphoma

Yves Beguin and Georges Weber

JCO Aug 15 2004: 3429. [Full Text] [PDF]

In Reply:

Kim W. Last, Ama Z.S. Rohatiner, Jude Fitzgibbon, and T. Andrew Lister

JCO Aug 15 2004: 3430. [Full Text] [PDF]

Is Rasburicase Needed for Prevention of Tumor Lysis Syndrome During Treatment of Less Aggressive Hematolymphoid Malignancies?

Syed Z.A. Zaidi and Mahmoud Aljurf

JCO Aug 15 2004: 3430-a–3431. [Full Text] [PDF]

In Reply:

Bertrand Coiffier

JCO Aug 15 2004: 3431–3432. [Full Text] [PDF]

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

U. Creutzig and G.J.L. Kaspers

JCO Aug 15 2004: 3432–3433. [Full Text] [PDF]

Errata

ERRATUM

JCO Aug 15 2004: 3434. [Full Text] [PDF]

ERRATUM

JCO Aug 15 2004: 3434-a. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.